We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bloomsbury Publishing Plc | LSE:BMY | London | Ordinary Share | GB0033147751 | ORD 1.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-2.00 | -0.37% | 542.00 | 534.00 | 542.00 | 556.00 | 540.00 | 544.00 | 40,850 | 16:04:45 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Books: Pubg, Pubg & Printing | 264.1M | 20.24M | 0.2497 | 21.71 | 439.34M |
Date | Subject | Author | Discuss |
---|---|---|---|
27/2/2022 20:07 | I sold my holding here last Friday for a reasonable profit, having enjoyed the rise up from the 330s. No choice, as I needed the cash for T20 settlements elsewhere. This is looking strong now and has recently been tipped as a buy in various places. I'll try and buy back in sometime on any weakness, providing I have available cash. Best of luck to anyone still holding. | notsoclever160 | |
23/2/2022 17:08 | Covered positively in this week's IC I believe | crazycoops | |
23/2/2022 15:39 | Fell just as quickly Momday and Tuesday. Just a standard rebound? | grahamburn | |
23/2/2022 15:24 | Price seems very strong today.Any ideas why | jbarcroftr | |
10/2/2022 19:47 | https://www.fool.co. | tole | |
08/2/2022 16:57 | Bloomsbury Publishing is a leading independent publishing house with a rich portfolio of authors who have won Nobel, Pulitzer and Booker Prizes. Most notably, they are the originating publisher of the Harry Potter series. With offices across Europe, USA, Australia, and Asia, company’s strategy is to discover and nurture quality authors, expand internationally, and increase digital resources revenue. Full year results reported in June are well ahead of expectations. Revenue reached £185m and boosted diluted EPS with 9%, at 18.68p. Good performance gave the opportunity for dividends to be raised as well and the Group announced a special dividend of 9.78p. Outlook for the start of FY 2022 is positive, based on good momentum. BMY’s expectations for FY22 are for profits to be ahead of current consensus....from WealthOracleAM | km18 | |
04/2/2022 12:48 | Stick this on a free thread too. Comment on MTEC, SCSW and their possible next moves. BMY will be tipped at the weekend but there are sellers in size about here too so any rally might not last long. Clearly if it is a stellar write up, volume might clear sellers but BMY carries a large spread, can't usually buy or sell in size, gaps out quickly. Not your usual trading share. Another big faller! They keep on coming. Valuation reset galore out there! Sometimes an SCSW tip can cause a short term pop higher, but I had a look at this on the tip and there were massive sellers in the market but folk absolutely piled in around that 122p mark. Someone has capitulated at 90p in selling 410k and a few other blocks being lobbed at 94p. Hard one to trade this though, it could have another big leg down in a flash. Traders will have to be nimble if indeed they choose to have a go. If I saw a few monster blocks being mopped up, I would be more tempted but the bottom on alot of these fallers is clearly hard to call. Out of the SCSW article, ADF was the one to look at imo - a fair few of us beat them to it. I suspect they will do a big write up on it tomorrow. They have already made readers aware that BMY will be tipped tomorrow and that a big write up on ADF is on its way. Judging by the way they have rushed to bring forward tomorrows release, it might include ADF i.e. wanting their readers to be able to get in before a big price rise. However, this is speculation on my part as it could be the month after. I am already long, but tempted to nibble a few more before the weekend. If a write up does come, and it does deliver, it could really get that share going. Again, speculation on my part. SCSW readers already know about this and will have positioned accordingly. They have had weeks to do so. MTEC 2.3p earnings in 2022, 6.1p earnings in 2023, 8.7p in 2024 Due a quick oversold bounce but a seller in size at 95p atm. Is it providing abit more value here? Hmm.... Being selective in this market with one eye on Putin. All imo DYOR | sphere25 | |
30/1/2022 11:43 | Thorpematt - many thanks for the info, much appreciated. A couple instances of that pattern then but also some instances of the opposite. I must get more acquainted with candlestick patterns. | zulu_principle | |
30/1/2022 11:40 | A little more coverage in the Daily Mail... | strollingmolby | |
30/1/2022 10:22 | If this was so, it would show in the daily candlestick chart. The pattern you describe would see a longish tail (typically defined as twice the range of the open versus close range), preferably it would show a close at the high of the day. This is know as a hammer. I have higlighted the hammers and any slighlty more tenuous examples of the daily movement you described here: - free stock charts from uk.advfn.com '> | thorpematt | |
28/1/2022 11:07 | Is anyone keeping tabs on intraday volume and price patterns? Thinking back over the past month (since I bought in) the price seems to fall back in the morning and recover during the afternoon once American traders and funds are active. Might be wishful thinking but I'm just wondering if the ABC-CLIO buy has encourraged more American interest than was previously the case. | zulu_principle | |
28/1/2022 05:59 | Peel Hunt upgrades 'excellent' BloomsburyPeel Hunt has upgraded publisher Bloomsbury (BMY), which the broker describes as 'an excellent story' that is 'well worth reading'.Analyst Malcolm Morgan upgraded his recommendation from 'hold' to 'buy' with a target price of 400p on the stock, which jumped 12.1%, or 40p, to a closing price of 370p on Wednesday after a strong trading update.Morgan noted 'revenue comfortably ahead and profit well ahead of market expectations'.'Suppl | tole | |
26/1/2022 08:31 | To be fair, BMY has trended sideways when most similar-sized stocks have shed 20%. "Comfortably" ahead rather sums up the lack of drama when holding BMY as opposed to the more "exciting" stuff. | thorpematt | |
26/1/2022 08:06 | Yep, good ahead statement, share price almost back to where it was last week on the old expectations. Shows sentiment overrules facts a lot of the time | dr biotech | |
26/1/2022 07:46 | Good track record of beating market forecasts being maintained. This must take current year PER to around 17x with a good 10% growth forecast for 2023. Caught up in the general market and smaller companies rout, but happy to add at these levels. | 18bt | |
26/1/2022 07:27 | Luvverly :-) Bloomsbury is pleased to announce that revenue is expected to be comfortably ahead and profit materially ahead of market expectations* for the year ending 28 February 2022. Trading continued to be strong in the Consumer division, for both Adult and Children's publishing. A major milestone has been hit by Bloomsbury Digital Resources ("BDR"). We are delighted to announce that on 18 January 2022, we achieved the goal announced in May 2016 that we would create the BDR division which would generate £15 million of sales and £5 million of profit by the year ending 28 February 2022. Six years later we have done exactly that. Achieving this key long-term strategic goal, building high margin, quality revenues, demonstrates the strength and successful execution of our digital strategy. | cwa1 | |
20/1/2022 17:14 | Bloomsbury featured here:- About 3.20 mins in if you don't want to watch it all... | cwa1 | |
15/1/2022 09:15 | One off SCSW tips for 2022. | charliec51 | |
15/1/2022 09:15 | One off SCSW tips for 2022. | charliec51 | |
17/12/2021 10:46 | Stock he'd never sell, thinks its under the radar. Some interesting bits on other stocks I hold too. | dr biotech | |
17/12/2021 10:27 | BMY latest thoughts from Richard Leonard, long term buy and hold. PIWORLD interview 39m57s | tomps2 | |
16/12/2021 07:36 | Looks a sensible use of the cash. | 18bt | |
16/11/2021 09:44 | I’m in today in the back of the scsw article. I’ve followed them for 18 months and have had some very good picks, but also a fair amount of dross too. Overall it’s been worth it. Basic summary is that he thinks the results will be well ahead of (19.1m) forecasts and that the share price could double over the medium term. | dr biotech | |
15/11/2021 09:47 | Apparently mentioned in SCSW over the weekend. Don't have the article myself | cwa1 | |
15/11/2021 09:42 | Very Perky | lancasterbomber |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions